Drug Search Results
More Filters [+]

Nandrolone

Alternative Names: nandrolone, nortestosterone, deca-durabolin, durabolin
Latest Update: 2023-11-14
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: AR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intramuscular,Subcutaneous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | Colombia | Dominican Republic | Ecuador | Egypt | Finland | Greece | Hong Kong | Hungary | India | Ireland | Italy | Jordan | Lebanon | Lithuania | Luxembourg | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Poland | Portugal | Russia | Serbia | Singapore | Slovenia | Sweden | Switzerland | Taiwan | Turkey | Ukraine | United Arab Emirates | United Kingdom | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Nandrolone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title